Runsheng Ma
Impact in
-
- Cancer, Lipids, and Metabolism
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
-
- Thyroid Cancer Diagnosis and Treatment
- Thyroid Disorders and Treatments
Papers in
-
- RNA modifications and cancer 4
- Circular RNAs in diseases 3
- Natural product bioactivities and synthesis 2
-
- Cancer-related molecular mechanisms research 3
- Cancer, Hypoxia, and Metabolism 3
- MicroRNA in disease regulation 2
- Cancer, Lipids, and Metabolism 2
- Co-authors
- Hongqiang Li (10 shared papers)Detao Yin (9 shared papers)Mengyuan Lei (3 shared papers)Jing Xie (1 shared paper)Kun Yu (1 shared paper)Zhen Liu (1 shared paper)Yongfei Wang (1 shared paper)Lele Zhang (3 shared papers)
In The Last Decade
Runsheng Ma
20 papers receiving 298 citations
Peers
Comparison fields: 5 of 69
- Cancer Research 96
- Endocrinology, Diabetes and Metabolism 81
- Molecular Biology 186
- Oncology 49
- Immunology 33
Countries citing papers authored by Runsheng Ma
This map shows the geographic impact of Runsheng Ma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Runsheng Ma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Runsheng Ma more than expected).
Fields of papers citing papers by Runsheng Ma
This network shows the impact of papers produced by Runsheng Ma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Runsheng Ma. The network helps show where Runsheng Ma may publish in the future.
Co-authors
The 25 scholars most cited alongside Runsheng Ma, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 70 | |
| 2 | 2021 | 29 | |
| 3 | 2017 | 24 | |
| 4 | 2023 | 22 | |
| 5 | 2021 | 21 | |
| 6 | Upregulation of the long non-coding RNA FOXD2-AS1 is correlated with tumor progression and metastasis in papillary thyroid cancer. | 2019 | 21 |
| 7 | 2018 | 20 | |
| 8 | 2021 | 19 | |
| 9 | 2020 | 18 | |
| 10 | 2021 | 16 | |
| 11 | 2021 | 13 | |
| 12 | 2022 | 8 | |
| 13 | 2025 | 5 | |
| 14 | 2023 | 3 | |
| 15 | 2024 | 3 | |
| 16 | 2022 | 2 | |
| 17 | 2025 | 2 | |
| 18 | 2021 | 2 | |
| 19 | 2022 | 1 | |
| 20 | 2019 | 1 |
About Runsheng Ma
Runsheng Ma is a scholar working on Molecular Biology, Cancer Research, Oncology, Endocrinology, Diabetes and Metabolism and Nephrology, having authored 20 papers that have together received 300 indexed citations. Recurring topics across this work include RNA modifications and cancer (4 papers), Thyroid Cancer Diagnosis and Treatment (4 papers), Cancer-related molecular mechanisms research (3 papers), Circular RNAs in diseases (3 papers), Cancer, Hypoxia, and Metabolism (3 papers), MicroRNA in disease regulation (2 papers), Natural product bioactivities and synthesis (2 papers) and Cancer, Lipids, and Metabolism (2 papers). The work is most often cited by research in Cancer Research (96 citations), Endocrinology, Diabetes and Metabolism (81 citations), Molecular Biology (186 citations), Oncology (49 citations) and Immunology (33 citations). Runsheng Ma has collaborated with scholars based in China and Australia. Frequent co-authors include Hongqiang Li, Detao Yin, Mengyuan Lei, Jing Xie, Kun Yu, Zhen Liu, Yongfei Wang, Lele Zhang, Tianshun Wang and Zunshui Cheng. Their work appears in journals such as Frontiers in Oncology, Inflammopharmacology, iScience, International Journal of Surgery and Molecular Carcinogenesis.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.